Velano Vascular's vascular access technologies transform care by seeking to reduce the stress and anxiety related to vascular access and blood draws during hospitalization. The company's technology innovations may reduce pain and discomfort for patients, and aims to enhance safety for providers. Velano is backed by First Round Capital, Kapor Capital, White Owl Capital, Safeguard Scientifics, The Children's Hospital of Philadelphia (CHOP), Griffin Hospital and dozens of healthcare industry veterans. The company's collaborators include leading U.S. hospital systems and organizations innovating in patient-centered care.
View Top Employees from Velano VascularWebsite | http://www.velanovascular.com |
Revenue | $18.6 million |
Funding | $55.9 million |
Employees | 17 (12 on RocketReach) |
Founded | 2012 |
Address | 221 Pine St 200, San Francisco, California 94104, US |
Phone | (844) 835-2668 |
Technologies |
JavaScript,
HTML,
PHP
+30 more
(view full list)
|
Industry | Retail, Medical Devices, Health Care, Executive Office, Medical, Medical Device |
Web Rank | 9 Million |
Keywords | Blood Draw Solution, Vaccine Survery Of The Prevalence Of Immunization Noncompliance, Velano Vascular, Needleless Peripheral Iv Lines, Needle-Free Blood-Drawing Technology |
Competitors | Ash Access Technology, Inc., Cardiologs, Marine Polymer Technologies, NeoChord, Inc., Tasso, Inc. |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Velano Vascular employee's phone or email?
The Velano Vascular annual revenue was $18.6 million in 2023.
Maryann Ciampa is the Vice President Business Development of Velano Vascular.
12 people are employed at Velano Vascular.
Velano Vascular is based in San Francisco, California.
The NAICS codes for Velano Vascular are [339, 33].
The SIC codes for Velano Vascular are [38, 384].